Telix names David Gill board chair

Reuters2026/08/31 22:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Telix appointed David Gill as board chair, effective immediately.
Gill joined the board in May 2026 as a non-executive director as part of succession planning.
He is a life sciences executive with 35 years’ experience in biopharma and medical devices, including radiopharmaceutical development and supply chains.
Gill previously served as CFO or president at EndoChoice Holdings, INC Research, and CTI Molecular Imaging.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief on September 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Telix names David Gill board chair

You may also like

Crypto prices